HL-60

Version 4.0.201701

Home - Cell Index - Search - Web Sites
Species - Tissues - Tumors - Pathologies - Tr. Agents
Collections - Laboratories - Catalogues

For information, get in touch with: Dott.ssa Paola Visconti
Email: paola.visconti@hsanmartino.it

P. Romano, A. Manniello et al. Nucl Acids Res 2009 37:D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105

This is the complete description of the cell line that you selected. By clicking on a generic term (e.g., SPECIES) you will go to the corresponding index (e.g., index of species), while by clicking on a specific term (e.g., retinoblastoma) you will go to the list of corresponding cell lines (e.g., retionoblastoma cell lines).

HL-60 (human, peripheral blood, leukemia, acute myeloid)

SPECIES: human
TISSUE/ORGAN: peripheral blood
TUMOR: leukemia, acute myeloid

DSMZ catalog code: ACC 3
Morphology: round, single cells in suspension
Susceptibility to viruses: HIV-1 * HTLV-1
Description: human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976; cells can be used for induction of differentiation studies; described to be responsive to DMSO, phorbol ester TPA and other reagents and to carry amplified c-myc gene; present cells are apparently tetraploid derivates of hypodiploid original where c-myc was amplified in dmin (instead of hsr) confirmed as human with IEF of MDH, NP
Viruses: ELISA: reverse transcriptase negative; PCR: EBV-, HBV-, HCV-, HHV-8-, HIV-, HTLV-I/II-
Depositor: Dr. E. Porfiri, The Royal Free Hospital, Department of Haematology, London, UK
General Restrictions

Available in the following LABORATORY:

German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig)
90% RPMI 1640 + 10% FBS maintain at 0.5-1.0 x 106 cells/ml, split 1:2 to 1:5 every 1-2 days; seed out at about 1 x 106 cells/ml at 37C with 5% CO2 maximal density of 1.5-2.0 x 106 cells/ml; doubling time of about 25 hours; frozen with 70% medium, 20% FBS, 10% DMSO at about 4-5 x 106 cells/ampoule; negative in DAPI, microbiological culture, RNA hybridization, PCR assays;
Validated by: cytogenetics 1 (hypotetraploid karyotype without clear mode, 1.5% polyploidy; 82(78-88)<4n>XX, -X, -X, -2, -3, -4, -5, -8, -9, -10, -14, -16, -17, -17, +3m, der(6)t(6;?)(q25;?)/dup(6)(q23;qter)x2, del(9)(p22), del(11)(q22/23), der(16)t(16;17)) * cytogenetics 2 ((q22/23;q21-22)x2; high frequency of subclonal ch 1 rearrangements) * DNA fingerprinting (unique Hinf I-(gtg)5 DNA profile) * immunological analysis (CD3- CD13+ CD14- CD15+ CD19- CD33+ HLA-DR-) * isoenzymes (confirmed as human with IEF of MDH, NP) * reverse transcriptase (not detected (RDDP assay))

Availability in cell line catalogues: ATCC: CCL 240, ICLC: HTL95010

Bibliographic references:

Blood 1979;54:713-733 - PMID: 288488
Blood 1988;71:242-247 - PMID: 3422031
Nature 1977;270:347-349 - PMID: 271272
Proc Natl Acad Sci U S A 1978;75:2458-2462 - PMID: 276884